跳至主要内容
临床试验/CTRI/2012/05/002623
CTRI/2012/05/002623暂停不适用

A comparative study of P6 acupressure and intravenous ondansetron for prevention of postoperative nausea and vomiting following intrathecal buprenorphine

Department of Anesthesiology1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2012年1月4日最近更新:

试验速览

阶段
不适用
状态
暂停
入组人数
120
试验地点
1
主要终点
P6 acupressure is effective in preventing post operative nausea and vomiting following intrathecal buprenorphine

研究概览

简要总结

120 patients fulfilling the above criteria will be included after written, informed consent. they will be randomly divided into 3 groups of 40 each named A, B, and C. Group A : acupressure group, Group B: 4 mg IV ondansetron group, and group C control. All patients will receive 2.8 to 3 ml of 0.5% heavy bupivacaine + 150 mcg buprenorphine in spinal anesthesia. all will maintain their bands/ sham bands for 24 hours postop and will be observed for occurrence of PONV

研究设计

研究类型
Interventional
分配方式
Random Number Table
盲法
Double Blind Double Dummy

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • ASA class I or II patients 2)Requiring orthopaedic surgery of the lower limbs under spinal anesthesia.

排除标准

  • Gastrointestinal disorders 2)Major systemic disease (ASA class III or more) 3)Obesity 4)Carpal tunnel syndrome and any deformity at the wrist 5)Known allergy to any of the study drugs 6)Contraindications to neuraxial blocks 7)On antiemetic drugs.

结局指标

主要结局

P6 acupressure is effective in preventing post operative nausea and vomiting following intrathecal buprenorphine

时间窗: intraoperative period, post operative period upto 12 hours

P6 acupressure is not effective in preventing post operative nausea and vomiting following intrathecal buprenorphine

时间窗: intraoperative period, post operative period upto 12 hours

次要结局

  • any possible adverse effects of acupressure compared with ondansetron(intraoperative and postoperative period)

研究者

申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

Comparison between an injection used for treating... | 临床试验